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Weight-loss is an integral part of Huntington’s disease (HD) that can start before the onset
of motor symptoms. Investigating the underlying pathological processes may help in the
understanding of this devastating disease as well as contribute to its management. How-
ever, the complex behavior and associations of multiple biological factors is impractical to
be interpreted by the conventional statistics or human experts. For the first time, we combine
a clinical dataset, expert knowledge and machine intelligence to model the multi-dimen-
sional associations between the potentially relevant factors and weight-loss activity in HD,
specifically at the premanifest stage. The HD dataset is standardized and transformed into
required knowledge base with the help of clinical HD experts, which is then processed by
the class rule mining and self-organising maps to identify the significant associations. Statis-
tical results and experts’ report indicate a strong association between severe weight-loss in
HD at the premanifest stage and measures of certain cognitive, psychiatric functional ability
factors. These results suggest that the mechanism underlying weight-loss in HD is, at least
partly related to dysfunction of certain areas of the brain, a finding that may have not been
apparent otherwise. These associations will aid the understanding of the pathophysiology of
the disease and its progression and may in turn help in HD treatment trials.
1. Introduction
Huntington’s disease (HD) is a devastating hereditary neurodegenerative disorder that results
in cognitive and neuropsychiatric abnormalities years before the motor issues start to appear,
on which the clinical diagnosis is based [1–3]. This is called the premanifest stage of the dis-
ease. Various neuroimaging studies indicated that in the premanifest-HD stage, patients show
redundant brain area recruitments. Functional magnetic resonance imaging (fMRI) studies
demonstrated abnormalities in cognitive domains in premanifest subjects when compared
with the healthy controls in certain areas such as response inhibition [4], verbal memory [5],
reward processing [6] and spatial working memory [7].
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The neuropathology of HD is emphasized by degeneration of certain brain areas, specifi-
cally the striatum [8]. On a cellular level, HD is caused by a genetic defect defined by a pro-
longed CAG (cytosine-adenine-guanine) sequence (expansion) in the Huntington gene (HTT)
[9]. Predictive genetic testing is used to identify individuals with the mutation before they
develop HD motor symptoms. These patients are known as pre-disease or premanifest.
The ability to identify the abnormal gene before disease symptoms onset offers an opportu-
nity to intervene at an early stage with potential treatments aimed at slowing disease progres-
sion or arresting it. Biomarkers are excellent tools for monitoring the disease progression and
measuring efficacy of treatment interventions. Although CAG repeat length is known to corre-
late well with disease progression, the complex nature of the disease and its varied presenta-
tions and severity amongst individuals with the same CAG repeat length, calls for more
biomarkers to understand disease progression in detail. Indeed, TRACK–HD study [10, 11]
has already shown useful clinical and imaging outcome measures to be used reliably in the
drug trials design.
Typically, HD starts when patients are in their thirties and forties. However, the age of
onset spans from infancy and to the ninth decade. The affected individual suffers gradual func-
tional decline and eventually requires intensive care and supervision, which often requires
extensive medical input and consumes significant family and social resources [12].
In addition to the above mentioned cognitive, psychiatric and motor symptoms, HD is
complicated by significant weight-loss. It is a gradual process and is known to have a negative
impact on mortality and the morbidity of the disease [13]. It occurs despite high calorie intake,
and is not associated with increased activity [14–21]. Furthermore, it has been shown that HD
patients who have high body mass index at the initial set of symptoms indicate slow rate of the
progression [22] which may provide useful indication for treatments.
It has long been established that unintended weight-loss is associated with HD disease
despite high energy diets [15] and this applies to even premanifest stages of the disease [19].
This suggests that the weight-loss in HD is unlikely to be causally related to the increase in
physical activity, for example, chorea. Indeed, in a randomized controlled prospective study
517 HD patients’ weight-loss was not found to correlate with motor scores such as chorea, dys-
tonia or the total UHDRS motor score (the Unified Huntington’s Disease Rating Score). It was
however found to be linked to CAG repeat length and the study findings implied that it is
likely to result from a hyper-metabolic state [23]. This study had excluded patients who were
taking neuroleptics which are associated with weight gain.
Other studies have shown that weight-loss is an integral part of the disease and could be in
part related to hypothalamic atrophy and dysfunction [24]. Evidence of hypothalamic involve-
ment by the disease pathology has been demonstrated in a number of studies [25]. It may
therefore be anticipated that the onset of weight-loss is related, at least in part, to the onset of
disease process, outside the striatum and cortex particularly the hypothalamus. This is particu-
larly important when assessing therapeutic agents’ effect on disease progression. Current ther-
apeutic trials are concentrating on treating HD in the premanifest stage or earlier. The
presence of neuronal dysfunction, whilst gene carrying individuals are still functioning, nor-
mally suggests that disease-modifying interventions should be initiated during this period
[10].
There exist a relatively limited range of studies that utilize the machine intelligence for
multi-factor analysis and early prediction of disease. For instance, study in [26] addresses
the use of pattern analysis and machine learning in the premanifest-HD subjects while using
various types of imaging datasets. The study indicated that 76% classification accuracy of pre-
manifest-HD versus the control subjects. The authors also indicated that using MRI measures
as biomarkers can be a useful approach for assessing the neuroprotective therapies in
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neurodegenerative disease. Orrù et al. [27], investigated the use of support vector machine as
method for the categorisation of patients’ unseen data into predefined groups using imaging
biomarkers for psychiatric and neurological diseases. Their analysis indicated that the support
vector machine and other machine learning algorithms provide promising results, however
substantial theoretical and practical works need to be performed to implement the outcome in
practical neurology and psychiatry. In [28], the authors indicated that there are various degrees
of heterogeneity among patients holding HD gene in which neuroimaging can provide impor-
tant cues to understand these heterogeneities. The authors claimed that most of the research in
the area of neuroimaging in HD concentrated on the differences between healthy and HD
patients. In their work, the authors indicated that using a combination of clinical and various
types of symptoms with multimodal approach can distinguish between the neural substrates of
various kinds of symptoms suffered by the HD patients.
Although aforementioned existing works focus on weight-loss in HD, these studies do not
specifically address the multi-dimensional associations between weight-loss and non-motor
factors specifically, at the important premanifest stage. Furthermore, the relationship between
the weight-loss and various non-motor factors at premanifest stage is never investigated.
These aspects should be investigated with appropriate statistical algorithms to analyse the com-
plex associations of weight-loss at early stages of HD which is the main motivation of this
study. Whilst large studies such as TRACK-HD [10] have identified important biological and
clinical parameters that can be used in longitudinal studies, weight-loss may also prove to be
an important and easily measurable surrogate marker for disease progression particularly at
the early stages which in turn could be helpful in therapeutic trials.
In order to further explore weight-loss in HD, the authors have undertaken this study to
model the associations between multiple factors specifically non-motor factors such as cogni-
tive, psychiatric factors and independence levels and weight-loss in premanifest-HD and fam-
ily control subjects. The pathophysiology of weight-loss in HD is far from clear and hence
adopting an open-minded approach is useful in unravelling such a complex problem. Deploy-
ing advanced data analytics techniques might have an advantage over the conventional statisti-
cal methods to analyze the complex patterns and potential associations between multiple
predefined factors and weight-loss. In this paper, we propose the implementation of an intelli-
gent approach utilizing pattern matching, class rule mining and domain knowledge for the
analysis of multiple factors and corresponding associations to severe weight-loss in the pre-
manifest stage of HD. For the first time, we attempt to investigate which specific fine-grained
cognitive, psychiatric and functional factors might be highly associated with the severe weight-
loss in premanifest-HD?
The major contributions of this work include a) The deployment of HD experts’
clinical knowledge for data representation and weight categorisation, b) Establishing
whether there is a strong association between the non-motor features and weight loss in HD?,
c) Pattern analysis by modeling the complex associations using self-organising maps and class
rule mining that is not possible with conventional statistical tools, d) Effective visualization of
high dimensional associations within the lower space using machine intelligence, e) Interpre-
tation of complex associations in form of distinct, significant and human understandable
rules.
This manuscript is organized as follows: Section 2 describes the detailed proposed method-
ology of knowledge representation, pattern analysis and association mining. The experimental
results and interpretation of representative rules are reported in section 3 followed by discus-
sion of the findings in section 4 and finally, the conclusion and future directions are presented
in Section 5.
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2. Methodology
Composite of data analytics techniques along-with the expert knowledge are utilized in this
study to analyse the complex patterns within the clinical records of HD dataset and to investi-
gate the significant associations between weight-loss and clinical factors specifically, for the
early stages of the disease. Fig 1 demonstrates the sequential procedure used in this study for
the hybrid analysis of identified associations and patterns. In the first step, the HD dataset
comprising patients and controlled subjects’ clinical records, is pre-processed to remove
anomalies and is then transformed into categorical form using clinical experts’ knowledge.
The processed dataset in the next step is then fed into different pattern analysis algorithms to
extract the human understandable patterns and significant associations between desired fac-
tors. These outputs are then validated using the standard statistical measures as well as human
experts to form the concluding remarks about inter-relationships between non-motor factors
and weight-loss at premanifest stage of the HD. Details about dataset, pre-processing, pattern
analysis and rule interpretation procedures are provided in the following sections.
2.1 Dataset
Enroll-HD is a global clinical research platform designed to facilitate clinical research in Hun-
tington’s disease. The dataset used in proposed study is owned by CHDI foundation (a bio-
medical research organization devoted to HD) [29]. Core datasets are collected annually from
all research participants as part of this multi-center longitudinal observational study. Data is
monitored for quality and accuracy using a risk-based monitoring approach. All sites are
required to obtain and maintain local ethical approval. We used the fourth Enroll-HD periodic
dataset comprising the clinical data from 15301 participants in total (premanifest/premotor,
manifest/motor-manifest HD, genotype negative and family control). Access to required HD
dataset was granted to authors by the CHDI team. For further details about appropriate proce-
dures, ethical approvals, contact details, and required terms and conditions can be found in
[29]. In this study, we use the premanifest (pMan-HD) and family control (fCont-HD), rec-
ords from the Enroll study comprising 8012 and 4427 records in total respectively. A fCont-
HD subject is defined as a person who is living/caring for the premanifest HD subject but
does not have the HD gene themselves, e.g., spouse. The dataset contains a variety of factors
Fig 1. A hybrid diagnostic approach using clinical domain knowledge and data analytics to learn the association
between severe weight-loss and biological factors in HD premanifest and control groups.
https://doi.org/10.1371/journal.pone.0253817.g001
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(i.e., variables) including the motor scores, functional abilities, cognitive, and psychiatric
scores etc. As the focus of this study is to investigate the association between severe weight-loss
and non-motor problems in HD, we include following factors: Cognitive scales: MMSE (mini
mental state examination) and sdmt (Symbol Digit Modality Test); functional independence
and capacity scores: indepscl (subjects’ independence), fiscore (functional score), tfcscore
(total functional capacity score); and psychiatric assessments: exfscore (executive function),
aptscore (apathy score), irascore (irritability/aggression score), depscore (depression score),
sdmt (symbol digit modality test), psyscore (phsychosis score) and wtCat (weight categories).
These factors are selected following the recommendations from clinical HD experts. Further
explanation of these factors, detailed data capturing procedures and information about PDS4
are available in [29].
2.2 Data preparation and domain knowledge representation
In the first step, we extract the required pMan-HD and fCont-HD records from the PDS4
dataset both containing the aforementioned list of selected factors. We then cleaned the data-
sets by eliminating the missing values/records and the outliers in each factor. More specifically,
the numeric factors such as tfscore, indepscore, irascore and motscore contains outliers that
were removed from both pMan-HD and fCont-HD datasets. Fig 2 shows an example of outli-
ers within the multiple factors in pMan-HD that were eliminated using box plot. The next and
important step after the data cleansing is to calculate the change in subjects’ weight over time.
The dataset in the primary form contains multiple records for each participant representing
the ‘baseline’ and ‘follow-up’ assessments/measurements recorded annually. Most of the sub-
jects contains 3–5 ‘follow-up’ records excluding the baseline. As per research question, we con-
sider the weight change (Δw) per subject across the entire period (i.e., from baseline to last







Where wb and wf represent the baseline and last follow-up weight of a subject respectively.
Algorithm 1 shows the procedure of Δw calculation within the pMan-HD and fCont-HD data-
sets. For each unique participant, the records are searched for the corresponding baseline and
last follow-up sample to measure the Δw. The algorithm runs recursively for each participant
(i.e., IDs) and corresponding follow-up records (i.e., T) with complexity of O(M � N) where M
Fig 2. Outlier removal examples using boxplot within the motscore, irascore and depscore factors in pMan-HD
records.
https://doi.org/10.1371/journal.pone.0253817.g002
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and N indicate the number of unique identities (i.e., participants) and corresponding follow-
ups respectively. This leads to eliminate the baseline and all intermediate follow-up records
from the datasets with remaining 1978 and 1191 data samples within the pMan-HD and
fCont-HD respectively, where each data sample represents an individual’s non-repeated
record.
Algorithm 1. Calculation of percentage weight change (Δw) within the
pMan-HD and fCont-HD.
INPUT: HD dataset D in raw form
OUTPUT: Output dataset OD with weight-change (Δw) measure
PROCEDURE:
- Let IDs contains the list of subjects’ identifications (ID)
Loop A: Foreach id in IDs
1. Find matching records in D (i.e. all records for 1
subject)
2. Store the records in a temporary data-frame T
3. Loop B: Foreach record r in T
a. IF r is a ‘Baseline’, THEN
i. Store the weight wb = weight (baseline)
b. IF r is the last ‘Follow-up’, THEN
i. Store the weight wf = weight (last follow-up)
4. End (Loop B)
5. Calculate the delta Δw using Eq (1)
6. Update the weight-Change Δw[id] in OD
7. Reset wb, wf, T to NULL
End (Loop A)
RETURN: OD (comprising Δw for each subject)
Once the Δw is calculated and unnecessary records are filtered out from the datasets, the
next step is to utilize the domain knowledge to transform the data into a Knowledge Base (KB)
that will be useful for pattern analysis and identification of potential associations between the
clinical factors.
Table 1 summarizes the multi-scale categories for each factor as transformed using knowl-
edge from clinical team of HD experts as well as the literature detailed in [29]. The weight-loss
is categorized as -3 (severe weight-loss) to +3 (severe weight gain) as with the case of other fac-
tors as detailed in Table 1. The final data representations for the pMan-HD and fCont-HD
contains the uniform representations of all factors (i.e., categorical dataset) forming the KB
which is forwarded to pattern analysis and association mining. Fig 3 shows the normalised fre-
quency distributions of the categorical factors within the pMan-HD and fCont-HD subjects. It
can be noticed that different factors have varying number of categories while mostly represent-
ing the normal (i.e., healthy) distributions. Both groups (fCont-HD and pMan-HD) demon-
strate some degrees of severity in domains such as depression, irritability, apathy and
executive function, but in slightly different frequencies. These can be used to investigate their
associations with weight-loss in HD.
2.3 Pattern analysis and rule mining
Analyzing the associations and patterns in high-dimensional datasets using conventional sta-
tistical approaches is impractical. The employment of machine intelligence for the analysis of
complex dataset and identification of patterns, have been significantly increased in various
domains such as medical imaging [30, 31], hand and facial gesture classification [32–34],
eHealth systems [35], unstructured medical data analysis [36, 37] and many more. The pMan-
HD in this study, contains 11 non-motor factors (see Table 1) each comprising multiple cate-
gories making it more complicated to be analysed by the human experts or conventional
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statistical approaches. The issue can be handled using intelligent pattern recognition algo-
rithms such as Self-Organizing Maps (SOM) which are the unsupervised form of artificial neu-
ral networks forming a non-linear projection of a high-dimensional space on a lower-
dimensions (typically 2-dimensioanl space) map [38]. SOM uses the competitive learning to
preserve the topological properties of an input space which is different from error minimiza-
tion algorithm used in other form of neural networks. The two-dimensional map representa-
tion is useful for pattern identification within the high dimensional data such as in this study.
During the competitive learning phase, the input data samples (i.e., one subject’s record in our
study) are iteratively mapped to SOM where a winning neuron (also called best matching unit)
is identified based on the distance from its weights and the input vector (i.e., one sample/
record from the dataset). The weight update is performed within the specific neighborhood
radius resulting in similar samples mapped closely together. In summary, the SOM algorithm
contains three major components that include: i) distance calculation between the input and
weight vector with time complexity O(N2 � S), ii) identifying the winning neuron with com-
plexity O(N � (S � log(S)), and iii) weight update using the neighborhood function with com-
plexity of O(N2 � S). Where, N and S represent the number of samples (i.e., dataset records)
and target classes (i.e., output neurons) respectively. Despite the categoric formation of the
dataset in this study, its numeric property is preserved to be used for the competitive learning-
based clustering algorithms. Detailed explanation and mathematical formulation of SOM can
be found in [38].
Table 1. Clinical domain expert knowledge based data transformation (numeric to categorized form).
Factors Expert knowledge-based categories of each factor
Age Age<30 30� age <40 40� age <50 50� age <60 60� age <70 age�70
0 1 2 3 4 5
wtCat 0� Δw <-5 -5� Δw <-10 -10� Δw <-20 -20� Δw
(weight categories) 0 (normal) -1 (moderate) -2 (severe) -3 (very severe)
mmsetotal 25�mmse 20�mmse <25 10�mmse <20 mmse <10
0 1 2 3
indepscl 0–40 41–80 81–95 �95
0 (severe) 1 (moderate) 2 (mild) 3 (normal)
fiscore fiScore 0–5 fiScore 6–10 fiScore 11–15 fiScore 16–20 fiScore > 20
0 (very severe) 1 (severe) 2 (moderate) 3 (mild) 4 (normal)
tfcscore 0–5 6–8 9–12 >12
0 (severe) 1 (moderate) 2 (mild) 3 (normal)
motscore Motscore = 0 Motscore: 1–31 Motscore: 32–62 Motscore: 63–93 Motscore > 93
0 (normal) 1 (mild) 2 (moderate) 3 (severe) 4 (very severe)
exfscore exfScore = 0 exfScore: 1–4 exfScore: 5–8 exfScore: 9–12 exfScore > 12
0 (normal) 1 (mild) 2 (moderate) 3 (severe) 4 (very severe)
aptscore aptScore = 0 aptScore: 1–4 aptScore: 5–8 aptScore: 9–12 aptScore > 12
0 (normal) 1 (mild) 2 (moderate) 3 (severe) 4 (very severe)
irascore iraScore = 0 iraScore: 1–4 iraScore: 5–8 iraScore: 9–12 iraScore > 12
0 (normal) 1 (mild) 2 (moderate) 3 (severe) 4 (very severe)
depscore depScore = 0 depScore: 1–4 depScore: 5–8 depScore: 9–12 depScore > 12
0 (normal) 1 (mild) 2 (moderate) 3 (severe) 4 (very severe)
psyscore psyScore = 0 psyScore: 1–4 psyScore: 5–8 psyScore: 9–12 psyScore > 12
0 (normal) 1 (mild) 2 (moderate) 3 (severe) 4 (very severe)
sdmt1 sdmt1>42 sdmt1: 35–42 sdmt1: 27–34 sdmt1: 0–25
0 (normal) 1 (mild) 2 (moderate) 3 (severe)
https://doi.org/10.1371/journal.pone.0253817.t001
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Fig 4(A) shows the SOM training progression and convergence while Fig 4(B) show the
count plot for pMan-HD data representing the sample distribution across the nodes within the
SOM map. The count plot relates to the quality of SOM model indicating a varying distribu-
tion of samples (20–80 samples in this case) over the map without empty nodes. The distribu-
tion of the dataset (samples and variables) across the SOM map can be visualised in two-
dimensional space using the heatmap which is one of the most useful property of SOM. In this
work, the heatmap is employed to identify the inter-relationships between multiple factors
within the pMan-HD and fCont-HD data.
Fig 5(A) demonstrates the wtCat distribution across the SOM nodes in pMan-HD subjects
where each sample of dataset in a node, represents a subjects’ clinical record for the selected
Fig 3. Normalised distribution (density) of the categorized factors (Table 1) within the pMan-HD and fCont
subjects.
https://doi.org/10.1371/journal.pone.0253817.g003
Fig 4. (a). SOM convergence during the training. (b). Count plot representing the records per node in SOM map for
pMan-HD data.
https://doi.org/10.1371/journal.pone.0253817.g004
PLOS ONE Weight-loss in Huntington’s disease at early stages
PLOS ONE | https://doi.org/10.1371/journal.pone.0253817 July 1, 2021 8 / 24
factors. The algorithm automatically organizes the map (i.e., position of samples and nodes)
based on Euclidean distance between the codebook vectors of neurons/nodes. In other words,
similar samples get together within same node. Likewise, nodes with high similarity (i.e.,
nodes with less neighboring distance) get together within the map whereas, dissimilar nodes
get far from each other. As an example, most of the subjects with severe weight-loss (i.e., wtCat
-3, -2) are pushed towards left positions (i.e., node 1, 4, 9, 14, 15) in Fig 5(A) representing the
similar behavior of wtCat factor in these subjects. On the other hand, most of the high weight
gaining (wtCat +3, +2) samples pushed themselves towards the right-side nodes (e.g., nodes 2,
3, 4, 7, 8, 11, 12, 16) in the map. This distribution clearly indicates the distinctive behavior of
weight-loss in pMan-HD subjects that needs further investigation in terms of its associations
with other biological factors. Fig 5(B) shows the codes plot which indicates a very useful infor-
mation about the combined behaviour of multiple factors across the SOM map. It can be
observed that the combined distribution is diverse across the map specifically in terms of
wtCat -3, -2. For instance, node 9 representing the severe weight-loss comprises medium age,
high tfcscore and indepscl whereas, node 1 indicate higher categories for sdmt and aptscore
while comparatively younger age group. Likewise, node 15 (representing the weight-loss) com-
prises high depscore and irascore in combination with younger age subjects.
Fig 6 further shows the distribution of individual factors across the SOM heat maps for
pMan-HD subjects. Firstly, the map indicates the overlapping distributions for tfcscore with
indepscl and depscore with irascore. This indicates correlation between these factors within
the pMan-HD subjects. Secondly, the heat maps indicate the relationship between each indi-
vidual variable and wtCat in pMan-HD. As an example, tfcscore and indepscl indicate high
categories for the severe weight-loss (i.e., wtCat -3, -2) whereas psyscore and exfscore indicate
an opposite behavior. On the other hand, age, depscore, irascore and sdmt indicate obscure
behavior which is needed to be further investigated.
The distribution of wtCat and combined factors in fCont-HD dataset is shown in Fig 7(A) and
7(B) respectively. It can be seen that the distributions of fCont-HD factors are different when com-
pared with the pMan-HD (Fig 6) indicating the varying inter-class associations in both groups.
Specifically, node 2, 3 (comprising wtCat -3, -2) indicate the presence of exfscore with tfcscore and
indepscl. Likewise, node 5, 6 indicate combinations of different factors as compared to pMan-HD
map. In summary, the SOM based lower-dimensional visualization clearly indicate the variations
in factors’ behavior and distributions in both groups (i.e., pMan-HD and fCont-HD) that needs
Fig 5. (a). Distribution of wtCat (-3 to +3) across the SOM nodes in pMan-HD subjects, (b). Codes plot distribution
of combined factors in SOM nodes. The node positions start from bottom left (node 1) and ends at top-right (node
16).
https://doi.org/10.1371/journal.pone.0253817.g005
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further investigation to explore the discrete inter-relationships specifically between the psychiatric
factors (such as irritability, sdmt, depression, apathy) and wtCat (-3, -2).
For this purpose, we utilize the Class Association Rules (CARs) which is the special case of
conventional rule mining [39] where the target class is only used as a consequent of rule. The
CARs have been utilized in various domains including healthcare, dimensionality reduction,
education and decision making [40–44]. One of the major uses of CARs is the identification of
frequent patterns within the large dataset that can easily be interpreted by the human experts
in form of rules. Let ‘F’be the list of factors defined in Table 1 containing T = {t1, t2, t3, . . . tN}
observations (i.e. subjects’ clinical records) in the dataset where each observation ‘ti’ contain-
ing a subset of factors ‘F’. The X!Y relationship in CARs indicates the disjoint itemset i.e.,
X\Y = ; occurring in the T (i.e., dataset) as antecedents and consequents respectively. An
important property of a rule is the corresponding support count (σ) representing the number
of observations containing that itemset (factor/s) and can be formulated as:
ðXÞ ¼ jftijX � ti; ti 2 Tgj ð2Þ
Fig 6. Heat maps representing the distribution of individual factors in pMan-HD across the SOM map.
https://doi.org/10.1371/journal.pone.0253817.g006
Fig 7. (a). Distribution of wtCat (-3 to +3) across the SOM nodes in fCont-HD subjects, (b). Codes plot indicating the
distribution of combined factors (fCont-HD subjects) in SOM nodes.
https://doi.org/10.1371/journal.pone.0253817.g007
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The strength of a rule (X) and hence the association are usually controlled by using confi-
dence (c) and support (s) metrics where:






where N represents the total number of observations/records within the dataset. The confi-
dence of a rule c represents the percentage for which factor Y occurs with the presence of factor
X and is represented as:






The strength of a rule usually identified by varying thresholds for ‘s’ and ‘c’ [45]. However,
the significance/importance of an association may be misinterpreted by these metrics. This is
because it only accounts for how popular the X is but not the Y. If the X occurs very frequently,
there will be a higher chance that an observation in the dataset containing the X will also con-
tain the Y, thus inflating the value of ‘c’ [45]. To account for the base popularity of both constit-
uent items (i.e., X and Y), a third measure called lift is used that measures the correlation
between X and Y of a rule, indicating the effect of the X on the Y, and is calculated as:




A value of lift(X)Y) = 1 indicates independence between antecedents and consequent,
whereas lift(X)Y)>1 indicates positive dependence of X and Y. We further deploy additional
measures to validate the strength of extracted rules. For instance, Conviction is a probabilistic
measure that incorporate the rules direction (an alternative to lift) with range 1 to1 (1 indi-
cate independence between X and Y). Chi-square metric and associated p-value represents the
confidence level of dependency between antecedents and consequent of a rule. Likewise, we
deployed the Strength measure generating 0 for negative correlation,1 for perfectly positive
correlations and 1 for independent X and Y. Detailed explanation about these metrics can be
found in [46].
To investigate the associations between specific factors (e.g., iraScore, sdmt, depScore etc.) as
antecedents and the consequent (wtCat -3 and wtCat -2) in this study, we utilise the CARs and
Apriori algorithm (with the computational complexity of O(2N) where N is the width of our
dataset) which are the well-established methods to identify the frequent patterns within the
dataset in the form of human understandable rules. A detailed explanation about CARs and
the Apriori algorithm can be found in [31]. The major challenge with the conventional rule
mining is the generation of high number of rules that is impractical to be interpreted by con-
ventional approaches or human expert. However, this issue is resolved using sequential filtra-
tion of irrelevant rules with varying threshold values for ‘c’ and ‘s’. Selection of optimum value
for these thresholds entirely depends upon the nature of problem and data itself [47]. Based on
imperical experiments, we perform the rule filtration while optimising several parameters that
include confidence (minimum confidence = 0.9), minimum length = 2, maximum length = 5
resulting the extraction of only highly associated and compact list of rules. As per research
question in this study, we extract conditional rules based on wtCat (-3 and -2) as consequent
that further limits the generation of large set of rules. In addition, we utilise the redundant
rules elimination [48] to filter the unecessary noise and therefore, resulting the list of represen-
tative rules that can easily be interpreted by the human experts.
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To further validate the SOM and CARs based outcomes, we deploy the Mutual Information
(I) which uses the Conditional Entropy C(H) indicating the uncertainty of a variable when
other is known and is given by:
CðHÞ ¼
P
ipðX ¼ xiÞHðYjX ¼ xiÞ ð6Þ
Where X and Y are random variables, p is the probabilty of known variable (X in this case)
and H is the entropy of Y conditioned on X. The I can be expressed as:
IðX;YÞ ¼ HðYÞ   HðYjXÞ ð7Þ
Where I(Y; X) measures the reduction of uncertainty on on Y (or X) due to the other vari-
able X (or Y). Both, C(H) and I can be used to test the conditional independence between mul-
tiple variables. For instance, higher I indicates higher dependency between two variables.
Further details and mathematical formulation of C(H) and I can be found in [49].
3. Experimental results
In order to investigate the potential class associations between the non-motor factors and weight-
loss in HD in premanifest stage, experiments are conducted using the KB categorised pMan-HD
and fCont-HD datasets comprising selected factors described in Table 1. The CARs algorithm is
used with the parametric configurations and rule filtration explained in Section 2.3 while consid-
ering the listed factors as antecedents and target wtCat as consequent for both pMan-HD and
fCont-HD. The specific focus of the experiments is to analyze the significant associations between
the severe weight-loss (i.e., subjects with wtCat -3, -2) and certain factors particularly the psychiat-
ric factors (such as irritability, depression, sdmt) and functional abilities in both groups.
Fig 8(A) demonstrates the 31 representative rules (shown as red circles) indicating the list
of factors highly associated with the severe weight lost (wtCat = -3) in the pMan-HD. The size
and colour intensity (i.e., red colour) of the circles relate to the relative strength of the rule in
terms of confidence and lift measure respectively. These non-redundant rules indicated high
association between wtCat = -3 and multiple factors such as moderate tfscore (1), mildly
affected exfscore (1), moderate aptscore (2), severe sdmt (3) and severe irascore (4). In a simi-
lar way, Fig 8(B) shows the associations for wtCat = -2 within the pMan-HD data. The plot
clearly indicates the excessive occurrence of high age (i.e., age = 5) subjects despite normal to
mild aptscore, sdmt and irascore. It also demonstrates an association of wtCat -2 with high apt-
score and exescore (2,3) or moderate depscores (1,2). The plot also demonstrates that wtCat-2
is associated with mild-moderate scores on sdmt (0,1).
Table 2 presents antecedents’ list for the rules shown in Fig 8(A). The statistical metrics vali-
date the strength of these associations indicating confidence >0.9, lift�125, conviction =1,
Chi-squared >124, p-value <7.4 e-29, and strength >1125. The p-value<<0.05 clearly indi-
cates the significant dependence between the antecedents and consequent (wtCat = -3) listed
in Table 2. As mentioned earlier (in Section 2.3), elimination of redundant rules and con-
straints over length of antecedents reduces the number of rules to the best representative rules
making them more easily understandable and interpretable by humans. Outcomes in Table 2
indicate the high representation of moderate to severe iraScore (2, 4), depScore (3, 4) and
tfscore (1) as well as severe scores on sdmt (2,3) when the antecedent is set to wtCat -3 within
the pMan-HD. It can also be noted that the list contains a relatively young age group (0–2)
associated to wtCat -3. Furthermore, it can be seen that the association of wtCat -3 with mod-
erate-severe sdmt appears in the same nonredundant rule as high depscore and irascores or in
rules when there is high aptscores. On the other hand, exfscore remains normal to mildly
affected in most of the cases.
PLOS ONE Weight-loss in Huntington’s disease at early stages
PLOS ONE | https://doi.org/10.1371/journal.pone.0253817 July 1, 2021 12 / 24
Table 3 presents the descriptive form of representative rules (antecedents only) shown in
Fig 8(B) with confidence >0.9, lift�27, conviction =1, Chi-squared >26, p-value <3.2e-07,
and strength >990. Similar to wtCat(-3) in pMan-HD subjects, those rules indicated strong
association between wtCat -2 and severe tfcscore (1) that occurs in combination with one of
the mild-moderate factors depscore, aptscore or sdmt in this case. On the other hand, irascore
indicates normal to mild measures across the rules except the cases where aptscore is normal
Fig 8. (a). Visualisation of representative associations between multiple factors and wtCat in preMan-HD (wtCat =
-3). (b). Visualisation of representative associations between multiple factors and wtCat in preMan-HD (wtCat = -2).
https://doi.org/10.1371/journal.pone.0253817.g008
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and age group is high(5) or in combination of moderated sdmt and exfscore. One of the inter-
esting aspects in Table 3 is the inverse behaviour indicated by aptscore and irascore (within
high age group) when appear together as antecedents. A high irascore appears in combination
with the normal-mild aptscore and vice versa. It is also worth noting that, sdmt, irascore and
exfscore indicate similar behaviour when combined together as antecedents. In summary, the
outcomes in Tables 2 and 3 indicate that with the severity levels of irascore, sdmt and depscore
increase with the progression of weight-loss from wtCat -2 to wtCat -3.
Although we utilised the rule filtration with parametric and non-redundancy constraints, it
is useful to present the antecedents’ information (i.e., rules) in a simpler form to better exam-
ine the features individually. For this purpose, we extracted the frequency histograms within
the antecedents of rules as shown in Fig 9. The frequency histograms help to visualise more
complex and large set of rules to further investigate the significance of individual factors within
the list of representative rules. However, it is important to consider the associations when ante-
cedents are combined with other factors (i.e., how the association varies with varying
Table 2. Antecedents in rules with high association between selected factors and severe weight-loss with wtCat =
-3 (consequent) in pMan-HD.
tfcscore = 1,depscore = 3,irascore = 4 sdmt1 = 3,irascore = 4,exfscore = 1
tfcscore = 1,sdmt1 = 0,irascore = 4 irascore = 4,aptscore = 2,exfscore = 1
tfcscore = 1,aptscore = 3,exfscore = 1 age = 1,depscore = 3,irascore = 4
tfcscore = 1,indepscl = 3,depscore = 3 indepscl = 2,irascore = 4,exfscore = 1
tfcscore = 1,depscore = 4,irascore = 2 sdmt1 = 3,depscore = 4,aptscore = 2
tfcscore = 1,irascore = 2,exfscore = 1 sdmt1 = 3,aptscore = 2,exfscore = 1
age = 2,tfcscore = 1,irascore = 2 age = 1,sdmt1 = 3,aptscore = 2
age = 2,tfcscore = 1,exfscore = 1 indepscl = 2,sdmt1 = 3,depscore = 4
tfcscore = 1,indepscl = 3,sdmt1 = 0 indepscl = 1,sdmt1 = 2,irascore = 2
age = 0,psyscore = 1,exfscore = 1 age = 1,depscore = 0,aptscore = 2
sdmt1 = 3,irascore = 4,aptscore = 2 sdmt1 = 2,depscore = 4,irascore = 2
indepscl = 2,sdmt1 = 3,irascore = 4
https://doi.org/10.1371/journal.pone.0253817.t002
Table 3. Antecedents in rules with high association between selected factors and severe weight-loss with wtCat =
-2 (consequent) in pMan-HD.
age = 5,exfscore = 2 tfcscore = 1,irascore = 0,exfscore = 1
depscore = 0,aptscore = 3 age = 5,sdmt1 = 1,aptscore = 3
age = 4,sdmt1 = 0,mmsetotal = 1 age = 5,aptscore = 3,exfscore = 1
tfcscore = 1,indepscl = 2,aptscore = 1 age = 5,irascore = 0,aptscore = 3
age = 1,tfcscore = 1,indepscl = 2 age = 5,indepscl = 2,irascore = 3
tfcscore = 1,indepscl = 2,irascore = 0 age = 5,irascore = 3,aptscore = 0
tfcscore = 1,sdmt1 = 1,aptscore = 1 age = 5,tfcscore = 3,indepscl = 2
tfcscore = 1,sdmt1 = 1,depscore = 2 age = 5,sdmt1 = 1,depscore = 2
age = 1,tfcscore = 1,sdmt1 = 1 age = 5,depscore = 1,aptscore = 1
tfcscore = 1,sdmt1 = 1,irascore = 0 age = 5,depscore = 2,irascore = 0
tfcscore = 1,depscore = 2,aptscore = 1 depscore = 1,irascore = 0,psyscore = 1
tfcscore = 1,irascore = 0,aptscore = 1 depscore = 2,aptscore = 2,exfscore = 3
tfcscore = 1,depscore = 2,exfscore = 1 irascore = 1,aptscore = 2,exfscore = 3
age = 1,tfcscore = 1,depscore = 2 age = 3,irascore = 0,aptscore = 3
tfcscore = 1,depscore = 2,irascore = 0 sdmt1 = 2,irascore = 3,exfscore = 2
{sdmt1 = 2,depscore = 2,exfscore = 2}
https://doi.org/10.1371/journal.pone.0253817.t003
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combinations in antecedents). Fig 9 presents the antecedents’ histogram for the representative
rules within the pMan-HD reflecting the Fig 8(A) and 8(B). These outcomes are aligned with
the aforementioned rules (Tables 2 and 3) indicating a mildly effected exfscore and moderate
to severe irascore, tfcscore, sdmt and depscore in wtCat -3. Likewise, tfcscore and exfscore in
wtCat -2 indicated slight change in behaviour in contrast to a decrease in the severity level of
depscore, sdmt and irascore which indicates the combined progression in weight-loss severity
and these factors.
Furthermore, the CARs outcomes are also aligned with SOM based distributions shown in
Figs 5 and 6. For instance, node 9, 14, 15 presents the low age distribution for wtCat -3 as com-
pared to node 1, 5 with moderate to severe age group for wtCat -2 that aligns with the CARs
outcomes. Likewise, high irascore and depscore appear in node 15 while normal to normal to
mild sdmt, aptscore appeared in most of the nodes with wtCat -2 which also aligns with the
CARs outcomes. However, as the distribution of wtCat comprises mixed occurrences within
the SOM map, the CARs produce comparatively discrete level information while conditioning
the target factor and constraints on antecedents.
Various similar works presented in Table 4 addressed the diverse aspects of the HD factors
at different stages sing different conventional statistical tools. For instance [15], reported that
the weight-loss in HD patients occurs with the disease progression which is not the case
Fig 9. (a). Antecedents’ histogram in CARs for pMan-HD subjects indicating individual factors’ frequency for wtCat
-3. (b). Antecedents’ histogram in CARs for pMan-HD subjects indicating individual factors’ frequency for wtCat -2.
https://doi.org/10.1371/journal.pone.0253817.g009
Table 4. Comparison of proposed study and existing works in this domain in terms of target variable, statistical algorithms, level of significance and explaining
attributes.
Study Factors Dependent variable Level of
significance
Method Disease stage
[11] Annualized disease progression quantitative imaging cognitive scores
motor scores
High Linear regression Premanifest and
early manifest HD
[15] Dietary, food quantity Weight gain/loss High Student t-test manifest
[23] CAG repeats Weight loss High Mixed effects model analysis manifest
[25] Weight loss, Non-motor features
(sleep, apathy)
Progression over time N/A Review of literature Manifest
[53] Psychiatric symptoms Progression over time High Linear mixed effect regression models Premanifest and
manifest
[54] Depression, Irritability, Apathy Progression over time Mild-High Multivariate linear regression analysis Mutation carriers/
premanifest
[55] Neuropsychiatric scale (PBA) Comparison of Neuropsychiatric
symptoms between different groups





Cognitive scales, functional score,
psychiatric assessments
Weight loss Moderate-High Self-Organising Maps, Class Rule
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otherwise (i.e., control group) [55]. reported the high prevalence of neuropsychiatric symp-
toms such as apathy, irritability, and executive dysfunction in HD specifically at premanifest
stage. However, despite the evidence of weight-loss over the disease progression, none of the
existing studies addressed the weight-loss relationship with the psychiatric features as in the
present work. Likewise, these works utilised the conventional statistical methods that are
impractical to identify the multi-dimensional associations within the complex data as well as
effective visualisation of the useful patterns within the complex data. In contrast, we employed
the SOM and CARs to help visualising and interpreting the complex patterns that are not pos-
sible with the tools used by existing works specifically, producing human understandable rules
and low-dimensional visualisations of complex patterns.
We further deploy the commonly used Chi-square test of independence and mutual infor-
mation I (Eqs 6 and 7) to investigate the conditional dependence between multiple factors and
severe weight loss (wtCat -3, -2) in pMan-HD. This analysis might be useful to validate the out-
comes retrieved through CARs based generated rules in Table 3. Table 5 presents the ‘I’ mea-
sure and test of independence outcomes between wtCat and other factors within the pMan-
HD data. It can be noticed that I measure is comparatively higher for age, tfscore, depscore,
irascore and aptscore for pMan-HD subjects. Likewise, the higher Chi-square value (�χ) and
corresponding p-values<0.05 (i.e., 95% confidence level) are also aligned with I measure for
these factors and indicate the significance of inter-dependence between these factors and
weight loss. These outcomes also align with most of the CARs rules specifically the histograms
presented in Fig 9. However, it is important to note that the statistical measure in Table 5 does
not consider the attribute interactions and multiple combinations. For instance, the combined
I for some factors (e.g., age, depscore, irascore) is significantly larger (I = 0.21) than corre-
sponding individual I measures in Table 5 (I = 0.04) which clearly indicate the impact of multi-
ple combinations within the wtCat-HD data. On the other hand, the CARs based
representative rules in Tables 2 and 3 are able to demonstrate the multiple combined factors
(identified as significantly associated with severe weight loss) based on various statistical mea-
sure including �χ, p-value, lift and conviction metrics.
Fig 10(A) summarises the representative rules for high associations between the wtCat -3
and rest of the factors within the fCont-HD data. In contrast to pMan-HD, the irascore and
sdmt being mild to moderate indicated high associations with wtCat -3 while depscore is vary-
ing from normal to severe levels. On the other hand, tfscore shows similar behaviour to pMan-
HD indicating the high association between severe weight-loss and severe tsfscore.
Table 5. Conditional information gain and Chi-square test of independence outcomes for weight-loss and other factors in pMan-HD and fCont-HD subject.
Factor (F) pMan-HD Subjects fCont-HD Subjects
I(wtCat)|F �χ p-value I(wtCat)|F �χ p-value
age 0.024 36.7 0.18 0.020 65.2 0.00
tfcscore 0.022 32.7 0.01 0.049 33.1 0.01
indepscl 0.008 22.8 0.02 0.029 17.4 0.13
sdmt1 0.025 21.5 0.25 0.042 19.4 0.36
mmsetotal 0.002 3.2 0.77 0.026 24.7 0.01
depscore 0.066 40.2 0.02 0.032 16.9 0.85
irascore 0.045 41.2 0.01 0.029 26.4 0.33
psyscore 0.006 9.4 0.14 0.001 6.5 0.36
aptscore 0.027 35 0.06 0.003 20.3 0.67
exfscore 0.020 28 0.25 0.029 45.4 0.00
https://doi.org/10.1371/journal.pone.0253817.t005
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Furthermore, the results indicate high degree of association between older ages and sever
weight-loss in fCont-HD.
Fig 10(B) show the representative associations (confidence,1 and lift� 21) between wtCat
-2 and other factors in fCont-HD. The outcomes indicate that a high depscore appears with
moderate irascore or aptscore in wtCat -2. Whereas high age group (4) and moderate
Fig 10. (a). Visualisation of representative associations between multiple factors and wtCat in fCont-HD for wtCat =
-3. (b). Visualisation of representative associations between multiple factors and wtCat in fCont-HD for wtCat -2.
https://doi.org/10.1371/journal.pone.0253817.g010
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indepscore indicate strong association with wtCat -2 in fCont subjects. Table 6 presents the
antecedents in representative rules shown in Fig 10(A) and 10(B) in descriptive form.
Fig 11 presents the histogram of individual antecedents in representative associations
within the fCont-HD subjects reflecting Fig 10(A) and 10(B). It can be observed that most of
the high frequency antecedents here indicated normal to mild category except depscore,
tfcscore and indepscore. These outcomes also overlapped significantly with the SOM based
codes plot in Fig 7, which also indicate low-to-mild values for exfscore, sdmt1 and aptscore in
most of the severe weight loss nodes (i.e. node 2 to 6).
Likewise, higher age group subjects appeared in most of the nodes representing wtCat -3, -2
while indepscl and tfcscore indicate varying distributions that also partially aligns with rules in
Table 6. In addition, the Chi-square test of independence and conditional information gain
values (shown in Table 5) further validate the outcomes of CARs (as shown in Table 6). For
instance, �χ, p-value and I measures indicate the significance of dependence between wtCat -3,
-2 and several factors including depscore, exfscore, age, indepscl and tfcscore that align with
the CARs outcomes. However, as previously mentioned, the major limitation of these methods
(Chi-square test and Information gain) is lack of simultaneous factor analysis and discrete
level information extraction for each factor. As an example, the joint mutual information I
(wtCat | tfcscore, sdmt1, depscore) and I(wtCat | age, sdmt1, depscore) increases to 0.22 and 0.31
respectively as compared to 0.04 (maximum) for individual factors. This indicate that various
combination of these factors might produce higher dependence with the severe weight-loss
that will be useful to be further investigated from a clinical perspective. However, identification
of optimal combination as well as factor level grained information extraction may be impracti-
cal with such methods. This overall show the leverage of CARs over conventional statistical
Table 6. Antecedents in rules with high association between selected factors and severe weight-loss (wtCat -3, -2)
in fCont-HD.
Consequent (wtCat) = -3 Consequent (wtCat) = -2
age = 5,tfcscore = 1 age = 4,tfcscore = 1
tfcscore = 1,depscore = 0 age = 4,indepscl = 1,sdmt1 = 3
tfcscore = 1,indepscl = 3 age = 4,indepscl = 1,depscore = 2
sdmt1 = 1,aptscore = 1,exfscore = 2 age = 4,indepscl = 1,irascore = 0
age = 4,indepscl = 1,aptscore = 0
sdmt1 = 2,depscore = 4,irascore = 2 depscore = 3,irascore = 1,aptscore = 2
irascore = 1,aptscore = 2,exfscore = 1
age = 5,sdmt1 = 2,exfscore = 1 depscore = 4,irascore = 2,exfscore = 1
https://doi.org/10.1371/journal.pone.0253817.t006
Fig 11. (a). Antecedents’ histogram in CARs for fCont-HD subjects indicating individual factors’ frequency for wtCat
-3. (b). Antecedents’ histogram in CARs for fCont-HD subjects indicating individual factors’ frequency for wtCat -2.
https://doi.org/10.1371/journal.pone.0253817.g011
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measures to analyse the complex associations and dependencies between combined multiple
factors at discrete level that can be understandable by humans.
4. Discussion
It has been established based on large scale studies such as PREDICT-HD and TRACK-HD
[10–11] that HD’s non-motor factors (such as depression, irritability, and cognitive dysfunc-
tion) start years before the onset of motor symptoms that defines the diagnosis of HD. Depres-
sion is amongst the most common psychiatric factors in HD, even decades before the onset of
the disease with the lifetime prevalence of major depression in 50% and above, compared to
15% in the normal population [50, 51]. Irritability is known to occur across all stages of the dis-
ease and studies have shown the prevalence to be 38–73% [52–54]. It is known to correlate
with depression and increases in severity in premanifest subjects as they come closer to devel-
oping the motor stage [54]. Apathy can start early in the disease but is known to progress as
the disease progresses. This is not the case with depression and irritability [10, 55]. Studies
have shown that although CAG repeat correlates with age of onset and speed of deterioration,
it does not necessarily correlate with the onset of severity of the psychiatric manifestations
[51].
Whilst the unequivocal motor factors of HD are associated with pathology in the basal gan-
glia and cerebral cortex and cognitive dysfunction is associated with pathology in the cortex
and the striatum parts of the brain, the underlying neurobiological mechanisms for these non-
motor factors are not known [25]. Understanding these may lead to important insight into
early disease mechanisms and hence aid in targeting therapy early on in the neurodegenerative
process.
Studies have suggested the involvement of the hypothalamus early in HD and given its role
in certain functions such as metabolism (weight control), and its involvement in early HD
symptoms, but its role is still unclear [25]. In this sense, the proposed study is aimed at investi-
gating the relationship of weight-loss and other non-motor factors in HD, in an attempt to
shed light on their neurobiology. In contrast to existing works that use conventional statistical
approaches (see Table 4), the proposed study might be useful for better visualisation of multi-
dimensional dataset and analysis of complex patterns producing human understandable rules
while utilising the clinical knowledge and machine intelligence.
The authors considered two categories of weight-loss: severe 10–20% of body weight
(wtCat-2) and very severe>20% of body weight (wtCat-3) at 3–5 year follow up in premanifest
HD subjects and family controls and studied its associations with cognitive, psychiatric and
functional independence measures. The results demonstrated a strong association of the
wtCat-3 with younger age group 1, 2 (30–50 years). This is in keeping with the established fact
that younger onset is associated with severe form of the disease. It also showed a clear associa-
tion of this category with moderate impairment on the total functional score when irritability
and depression severity are high or when functional scores are moderately impaired
tfcscore = 1, combined with moderate/high apathy scores and mild executive dysfunction
scores. Interestingly from these rules of associations, it seems that subjects who are losing
weight severely and are functionally moderately impaired have one of two predominant pic-
tures: irritability and depression or apathy and executive dysfunction but not both. This is in
keeping with studies highlighted previously [10, 50–55] that have shown an association of
depression and irritability. Apathy on the other hand seems independent and possibly unre-
lated to irritability and depression in HD. Furthermore, the findings of the study are in keep-
ing with the studies that suggest that apathy may start early in the disease. Another interesting
finding is that in this group of subjects, there is an association with moderate scores on the
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cognitive scores (sdmt), again implying that subjects with severe disease as denoted by the
extreme catabolic state have evidence of moderate to severe cognitive impairment early on in
the disease process, i.e. in the premanifest stage. Interestingly, this was not the case with
MMSE (i.e., mmsetotal), adding further evidence that sdmt may be more sensitive at detecting
cognitive dysfunction in HD. This has already been demonstrated in the TRACK-HD study
[11].
The results in the other category wtCat -2 in premanifest subjects demonstrate slightly dif-
ferent associations. In this case, weight-loss was associated largely with older age (>60 years),
again with moderate functional independence impairment, tfcscore 1 and either moderate
depression or high apathy scores. It is difficult to establish from these findings whether late
onset disease as in this group is associated with more prominent apathy and executive scores.
In the family control group of subjects, the distribution of the age is different which may
affect the results in that the highest number was in age group (50–70 years) shown in Fig 2.
However, as one would expect, wtCat -2 was associated with severe depression (scores 2, 3)
and mild irritability and apathy. On the other hand, extreme weight-loss was associated with
older age and moderate functional impairment without depression. This may mean that the
weight-loss is attributed to a second pathology. Only in one rule did severe depression come
up in this group, interestingly in association with moderate cognitive scores, sdmt = 2.
This work is a preliminary study looking at a novel way of assessing multiple clinical param-
eters with complex associations with a combination of machine intelligence and clinical
domain knowledge. The authors believe, that provided the parameters are selected carefully by
a clinical expert and categorized, significant correlations can be better studied compared with
the case of adopting classical statistical approach. There are few shortcomings in the study
(especially in relation to attribute interaction and related domain knowledge) that would need
to be refined before a larger and more extensive study could be undertaken.
5. Conclusions and future directions
This paper uses a combination of clinical domain expert knowledge and data analytics algo-
rithms to investigate the non-motor features of Huntington’s disease (HD) that may be highly
associated with severe weight-loss, specifically, in the early premanifest/non-motor stage. We
transformed a 5 year Enroll-HD dataset into knowledge base (i.e., the categorical form) driven
by clinical expertise, which was then processed by the intelligent algorithms to identify the
complex behaviors of selected factors. The study performed detailed analysis using well estab-
lished clustering and class rule mining algorithms to investigate weight-loss associations with
multiple non-motor factors in the premanifest stage of HD. Our results demonstrate that cer-
tain psychiatric features, namely depression, irritability and apathy as well as cognitive
impairment and functional independence were significantly associated with severe weight-loss
in the premanifest stage of HD. This is a potentially important finding, implying that weight-
loss could be used as a biological marker in the early stages of the disease. These results may
also be investigated further in future studies aiming at understanding the dysfunction of neu-
ronal circuits in HD. Furthermore, using this clinical expertise informed analytics approach
lends itself to being applicable across later stages of HD, to help investigate whether weight-
loss could be used as a biological marker for disease monitoring in therapeutic trials.
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